glp 1 and gip Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research GLP-1 vs. GLP-1 + GIP:

The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease

Eligibility for a GLP-1 medication depends on a Service Members diagnosis, prior authorization, and/or medical necessity.Service Members who are overweight with other risk factors or obese should work with their Department of War (DoW) medical officer or Primary Care Manager/Provider to determine if a GLP-1 medication is appropriate before starting these medications.The use of GLP-1 medications during training, deployments, or operational platforms might not be authorized

Learn how standard titration and microdosing compare and why a licensed provider should guide your dosing plan.

Differences between agents highlight the importance of individualized treatment strategies, complemented by nutritional and exercise interventions to optimize long-term outcomes.

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc

This state-of-the-art narrative review synthesizes current evidence from clinical trials, pharmacovigilance databases, and real-world cohorts to provide a comprehensive evaluation of the safety and tolerability of GLP-1RAs and tirzepatide